journal article·2026-01Open access

Synergistic fusion of CD47, VE-cadherin and mussel adhesion protein promotes endothelialization and suppresses inflammation in vascular stents

Wenhua Yan, Shuyu Li, Tian Zhang, Junli Huang, Chengchen Deng, Kunshan Yuan, Nan Huang, Haijun Zhang, Guixue Wang

Abstract

Endothelial cell (EC)-specific coatings for vascular stents are crucial for enhancing their biocompatibility and preventing complications such as restenosis and thrombosis. This study developed an innovative CD47-VE-cadherin-Mfp5 (CD47-VE-M) fusion protein coating for cardiovascular stents that integrates three distinct functional domains: endothelial adhesion enhancement (VE-cadherin EC1-2), macrophage inhibitory signaling (CD47), and substrate adhesion reinforcement (Mfp5). In vitro , CD47-VE-M coatings significantly promoted EC adhesion (3.4-fold increase vs. bare-metal stent (BMS) (p < 0.001)), directional migration (accelerated 62 % compared to BMS at 24 h) and proliferation (2.3-fold increase vs. BMS (p < 0.01)), with increased VE-cadherin expression and improved tight junction formation (1.5-fold higher than BMS (p < 0.001)). Additionally, the CD47-VE-M coating reduced macrophage phagocytosis by 59 % (p < 0.01). Compared with BMS, synergistic CD47-VE-M fusion protein-coated stents showed accelerated endothelialization and reduced neointimal hyperplasia and restenosis by 64.4 % (p < 0.001) in vivo . Besides, the coating also decreased the presence of M1 pro-inflammatory macrophages (64.74 % decrease vs. BMS (p < 0.01)), which mitigated the inflammatory response. This novel coating strategy overcomes the limitations of current drug-eluting stent (DES) by simultaneously enhancing endothelial regeneration and suppressing pathological inflammation. Synergistic integration of CD47, VE-Cadherin, and mussel adhesion protein enhances endothelialization and attenuates inflammatory responses in vascular stents. • CD47-VE-Cadherin-Mfp-5 (CD47-VE-M) fusion protein was synthesized for the first time. • CD47-VE-M coatings promote endothelial repair, suppress macrophage phagocytosis in vitro. • Dual-functional stent accelerates endothelialization and reduces restenosis in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Phagocytosis and Immune Regulation · Cell Adhesion Molecules Research · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (64)

Show source-provided references
1. Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease10.1056/NEJMoa2305637 ↗
2. Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the academic research consortium10.1161/CIRCULATIONAHA.123.064473 ↗
3. Anti-Atherosclerotic therapies: milestones, challenges, and emerging innovations10.1016/j.ymthe.2022.08.024 ↗
4. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside10.1093/cvr/cvac105 ↗
5. A drug-free cardiovascular stent functionalized with tailored collagen supports in-Situ healing of vascular tissues10.1038/s41467-024-44902-2 ↗
6. A bio-inspired nanoparticle coating for vascular healing and immunomodulatory by Cgmp-Pkg and Nf-Kappa B signaling pathways10.1016/j.biomaterials.2023.122288 ↗
7. Randomized comparison of novel low-dose sirolimus-eluting biodegradable polymer stent Vs second-generation des: Target-IV Na trial10.1016/j.jacc.2024.10.074 ↗
8. Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in St-Segment elevation myocardial infarction: 5-year Follow-Up of the biostemi randomised superiority trial10.1016/S0140-6736(23)02197-9 ↗
9. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment10.1016/S1474-4422(21)00376-8 ↗
10. An integrated arterial remodeling hydrogel for preventing restenosis after angioplasty10.1002/advs.202307063 ↗
11. Polyphenol-network-mediated coating modulates inflammation and vascular healing on vascular stents10.1021/acsnano.2c00642 ↗
12. Biliary stents for active materials and surface modification: recent advances and future perspectives
13. "Built-Up" composite film with synergistic functionalities on Mg-2Zn-1Mn bioresorbable stents improves corrosion control effects and biocompatibility
14. Biosafety and efficacy evaluation of a biodegradable zn-cu-mn stent: a long-term study in porcine coronary artery
15. Mussel adhesive protein fused with Ve-Cadherin extracellular domain promotes endothelial-cell tight junctions and in vivo endothelization recovery of vascular stent10.1002/jbm.b.34369 ↗
16. Timp2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting src-dependent Ve-Cadherin internalization10.1172/JCI164199 ↗
17. Vascular Flrt2 regulates venous-mediated angiogenic expansion and cns barriergenesis10.1038/s41467-024-54570-x ↗
18. Ubiquitin ligase chfr mediated degradation of Ve-Cadherin through ubiquitylation disrupts endothelial adherens junctions10.1038/s41467-023-42225-2 ↗
19. Crosstalk between adenosine receptors and Cyp450-Derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response10.1016/j.pharmthera.2022.108213 ↗
20. Coronary stent Cd31-Mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo10.1093/eurheartj/ehab027 ↗
21. Baicalin-based composite coating for achieving biological multifunctionality of vascular stents10.1016/j.jconrel.2025.01.005 ↗
22. A self-sacrificing anti-inflammatory coating promotes simultaneous cardiovascular repair and reendothelialization of implanted devices
23. Molecular pathways: activating T cells after cancer cell phagocytosis from blockade of Cd47 "Don't Eat Me" Ssgnals10.1158/1078-0432.CCR-14-2520 ↗
24. Increase in charge and density improves the strength and toughness of mussel foot protein 5 inspired protein materials10.1021/acsbiomaterials.3c00088 ↗
25. A natural adhesive-based nanomedicine initiates photothermal-directed in situ immunotherapy with durability and maintenance10.1016/j.biomaterials.2024.122751 ↗
26. Bi-Terminal fusion of intrinsically-disordered mussel foot protein fragments boosts mechanical strength for protein fibers10.1038/s41467-023-37563-0 ↗
27. Mytilus Edulis foot protein mimics for tailoring long-acting endothelium-mimicking anti-thrombotic surfaces
28. Aspirin plus Rivaroxaban versus Rivaroxaban alone for the prevention of venous stent thrombosis among patients with post-thrombotic syndrome: the multicenter, multinational, randomized, open-label ariva trial10.1161/CIRCULATIONAHA.124.073050 ↗
29. Optical coherence tomography predictors of clinical outcomes after stent implantation: the ilumien IV trial10.1093/eurheartj/ehae521 ↗
30. M2 macrophage-derived exosomes promote the C-Kit phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation10.7150/thno.46143 ↗
31. A high-performance chitosan-grafted Cu(Ⅱ) coating improves endothelialization and mitigates the degradation of biodegradable magnesium alloy stents10.1016/j.biomaterials.2025.123161 ↗
32. Gas station in blood vessels: an endothelium mimicking, self-sustainable nitric oxide fueling stent coating for prevention of thrombosis and restenosis10.1016/j.biomaterials.2023.122311 ↗
33. Engineered endothelium model enables recapitulation of vascular function and early atherosclerosis development10.1016/j.biomaterials.2024.122889 ↗
34. Ve-Cadherin endocytosis controls vascular integrity and patterning during development10.1083/jcb.201909081 ↗
35. "Synergistic Anticoagulant and Endothelial Regeneration Strategy" based on mussel-inspired phospholipid copolymer coating and Bioactive zeolitic imidazolate Frameworks-90 to maintain the patency of cocr stent
36. Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis10.1093/eurheartj/ehac647 ↗
37. Synthesis and characterization of amine-functionalized graphene as a nitric oxide-generating coating for vascular stents10.1063/5.0192379 ↗
38. Ccn5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin Β4 and Cd9 pathway10.1093/eurheartj/ehae911 ↗
39. Platelet membrane decorated exosomes enhance targeting efficacy and therapeutic index to alleviate arterial restenosis10.7150/thno.103747 ↗
40. Mechanical and physio-biological properties of peptide-coated stent for Re-Endothelialization10.1186/s40824-020-0182-x ↗
41. Biomimetic ros-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis10.1093/rb/rbae102 ↗
42. Plx3397, a Csf1 receptor inhibitor, limits allotransplantation-induced vascular remodelling10.1093/cvr/cvab289 ↗
43. Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing10.1016/j.actbio.2024.02.022 ↗
44. Senescent endothelial cells' response to the degradation of bioresorbable scaffold induces intimal dysfunction accelerating in-Stent restenosis10.1016/j.actbio.2023.05.028 ↗
45. Riding a vascular time train to spatiotemporally attenuate thrombosis and restenosis by double presentation of therapeutic gas and biomacromolecules
46. Co-Loaded Hemoglobin/Egcg nanoparticles functional coatings for inflammation modulation of vascular implants10.1093/rb/rbae148 ↗
47. Versatile effects of Galectin-1 protein-containing lipid bilayer coating for cardiovascular applications
48. First-in-Human phase I trial of the bispecific Cd47 inhibitor and Cd40 agonist Fc-Fusion protein, Sl-172154 in patients with platinum-resistant ovarian cancer10.1136/jitc-2024-010565 ↗
49. Sirpalpha-Fc fusion protein Imm01 exhibits dual anti-tumor activities by targeting Cd47/Sirpalpha signal pathway via blocking the "Don't Eat Me" Signal and Activating the "Eat Me" Ssgnal10.1186/s13045-022-01385-2 ↗
50. Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces
51. A facile metal-phenolic-amine strategy for dual-functionalization of blood-contacting devices with antibacterial and anticoagulant properties10.1039/C8QM00458G ↗
52. A versatile surface bioengineering strategy based on mussel-inspired and bioclickable peptide mimic
53. Endothelium-mimicking multifunctional coating modified cardiovascular stents via a stepwise Metal-Catechol-(Amine) surface engineering strategy
54. Bio-inspired lotus-fiber and mussel-based multifunctional hydrogels for wound healing: super-stretchability, self-healing, adhesion and antibacterial properties10.1093/rb/rbaf031 ↗
55. Lithium-induced optimization mechanism for an ultrathin-strut biodegradable Zn-Based vascular scaffold10.1002/adma.202301074 ↗
56. Additive manufacturing of biodegradable molybdenum - from powder to vascular stent10.1002/adma.202401614 ↗
57. Incorporating copper to biodegradable magnesium alloy vascular stents via a Cu(II)‐Eluting coating for synergistic enhancement in prolonged durability and rapid re‐endothelialization
58. Mussel-inspired Dopamine-Cu II coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis10.1016/j.biomaterials.2018.12.020 ↗
59. Spatiotemporal dual-delivery of therapeutic gas and growth factor for prevention of vascular stent thrombosis and restenosis
60. Hierarchical capillary coating to biofunctionlize drug-eluting stent for improving endothelium regeneration
61. Peptide vaccine against Adamts-7 ameliorates atherosclerosis and postinjury Neointima Hyperplasia10.1161/CIRCULATIONAHA.122.061516 ↗
62. In situ H2 S-Releasing stents optimize vascular healing10.1021/acsnano.4c16345 ↗
63. Structural and temporal dynamics analysis on drug-eluting stents: history, research hotspots and emerging trends
64. Structural and temporal dynamics analysis of zinc-based biomaterials: history, research hotspots and emerging trends